SEER, INC. (SEER) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $725.72M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-336.00K; Retained Earnings (Accumulated Deficit)USD $-499.71M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $724.35M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-64.00K; Retained Earnings (Accumulated Deficit)USD $-482.81M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $724.82M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $459.00K; Retained Earnings (Accumulated Deficit)USD $-465.97M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $721.36M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $431.00K; Retained Earnings (Accumulated Deficit)USD $-449.98M.
SEER, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | Treasury Stock Acquired, Average Cost Per Share USD/shares | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings USD |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $725.72M | $-336.00K | $-499.71M | $225.68M | 3 month · $1.58M | 3 month · 1.68 6 month · 1.77 | (m) | (m) |
| 2026-03-31 | $0.00 | $724.35M | $-64.00K | $-482.81M | $241.48M | 3 month · $2.14M | 3 month · 1.78 | (m) | (m) |
| 2025-12-31 | $0.00 | $724.82M | $459.00K | $-465.97M | $259.31M | 12 month · $15.58M | 12 month · 1.93 | (m) | (m) |
| 2025-09-30 | $0.00 | $721.36M | $431.00K | $-449.98M | $271.81M | 3 month · $3.62M | 3 month · 1.99 9 month · 1.93 | (m) | (m) |
| 2025-06-30 | $0.00 | $719.73M | $307.00K | $-431.74M | $288.29M | 3 month · $3.93M | 3 month · 1.92 6 month · 1.92 | (m) | (m) |
| 2025-03-31 | $0.00 | $723.02M | $305.00K | $-412.32M | $311.01M | 3 month · $4.72M | 3 month · 1.91 | (m) | (m) |
| 2024-12-31 | $0.00 | $719.80M | $136.00K | $-392.37M | $327.57M | 12 month · $28.43M | 12 month · 1.82 | (m) | (m) |
| 2024-09-30 | $0.00 | $714.57M | $789.00K | $-370.63M | $344.73M | 3 month · $6.58M | 3 month · 1.78 9 month · 1.80 | (m) | (m) |
| 2024-06-30 | $0.00 | $714.63M | $-626.00K | $-349.30M | $364.70M | 3 month · $7.70M | 3 month · 1.84 6 month · 1.84 | (m) | (m) |
| 2024-03-31 | $0.00 | $710.53M | $-521.00K | $-326.45M | $383.56M | 3 month · $7.66M | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $702.87M | $-192.00K | $-305.77M | $396.90M | 12 month · $34.42M | (m) | (m) | (m) |
| 2023-09-30 | $0.00 | $694.95M | $-1.30M | $-287.97M | $405.68M | 3 month · $8.33M | (m) | (m) | (m) |
| 2023-06-30 | $0.00 | $686.54M | $-1.53M | $-266.89M | $418.12M | 3 month · $9.75M | (m) | (m) | (m) |
| 2023-03-31 | $0.00 | $676.54M | $-93.00K | $-243.46M | $432.99M | 3 month · $8.72M | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | $667.74M | $-1.25M | $-219.50M | $446.99M | 12 month · $33.67M | (m) | 12 month · $33.67M | (m) |
| 2022-09-30 | $0.00 | $657.43M | $-2.69M | $-196.97M | $457.77M | 3 month · $9.07M | (m) | (m) | (m) |
| 2022-06-30 | $0.00 | $648.15M | $-3.11M | $-172.99M | $472.04M | 3 month · $8.38M | (m) | (m) | (m) |
| 2022-03-31 | $0.00 | $638.86M | $-2.23M | $-150.18M | $486.46M | 3 month · $8.06M | (m) | (m) | (m) |
| 2021-12-31 | $0.00 | $629.98M | $-536.00K | $-126.53M | $502.92M | (m) | (m) | 12 month · $25.93M | (m) |
| 2021-09-30 | $0.00 | $621.99M | $-8.00K | $-106.79M | $515.20M | 3 month · $6.79M | (m) | (m) | (m) |
| 2021-06-30 | $0.00 | $614.48M | $-34.00K | $-88.41M | $526.04M | 3 month · $6.43M | (m) | (m) | (m) |
| 2021-03-31 | $0.00 | $607.53M | $28.00K | $-71.79M | $535.77M | 3 month · $6.04M | (m) | (m) | (m) |
| 2020-12-31 | $0.00 | $486.92M | $54.00K | $-55.36M | $431.61M | (m) | (m) | 12 month · $7.35M | 12 month · $40.00K |
| 2020-09-30 | (m) | (m) | (m) | (m) | $125.54M | 3 month · $1.18M | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | $132.70M | 3 month · $808.00K | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | $83.33M | 3 month · $579.00K | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | $87.68M | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |